NetworkNewsBreaks – Avricore Health Inc. (TSX.V:
Post# of 61
Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) recently rolled out its trademarked HealthTab network technology platform, which uses Abbott Afinion 2(TM) analyzers for assessing cardiovascular and diabetes markers, in 12 Shoppers Drug Mart locations. Between July 5 and July 18, Avricore conducted an initial trial period of the health management data platform in an Ontario, Canada-based Shoppers Drug Mart store and found that more than 90 patients were tested and over 600 results were reported during the week and a half period. A recent article reads, “‘This is really profound because having access to lab-accurate results at our fingertips means we can better help family physicians by conducting regular follow up using advanced diagnostics with our diabetic and cardiovascular patients more effectively,’ pharmacist and associate owner Mohamed Adel Elsabakhawi stated. The purpose of the rollout is to help patients, beginning in Ontario, to live life well using effective tools and services to successfully manage their overall health with the support of a trusted pharmacist.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer